NM_004260.4:c.214-3C>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004260.4(RECQL4):c.214-3C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000563 in 1,597,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004260.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152250Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.0000555 AC: 12AN: 216030Hom.: 0 AF XY: 0.0000504 AC XY: 6AN XY: 119120
GnomAD4 exome AF: 0.0000346 AC: 50AN: 1445030Hom.: 0 Cov.: 36 AF XY: 0.0000334 AC XY: 24AN XY: 718104
GnomAD4 genome AF: 0.000263 AC: 40AN: 152368Hom.: 0 Cov.: 35 AF XY: 0.000228 AC XY: 17AN XY: 74522
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
In silico analysis, which includes splice predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
DNA sequence analysis of the RECQL4 gene demonstrated a sequence change in intron 3, c.214-3C>A. This change does not appear to have been previously described in individuals with RECQL4 -related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.082% in the African American subpopulation (dbSNP rs367849648). In-silico splice prediction programs provide inconclusive results for this sequence change. The functional significance of this sequence change is not known at present and its contribution to this individual's disease phenotype cannot definitively be determined. -
Rothmund-Thomson syndrome type 2 Uncertain:1
The RECQL4 c.214-3C>A intronic change results from a C to A substitution at the -3 position of intron 3 of the RECQL4 gene. Algorithms that predict the impact of sequence changes on splicing indicate that this variant does not affect splicing (BP4), but to our knowledge these predictions have not been confirmed by RNA studies. This variant has a maximum subpopulation frequency of 0.081% in gnomAD v2.1.1. To our knowledge, this variant has not been reported in individuals with RECQL4-associated disorders. In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: BP4. -
Baller-Gerold syndrome Uncertain:1
This sequence change falls in intron 3 of the RECQL4 gene. It does not directly change the encoded amino acid sequence of the RECQL4 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs367849648, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 406957). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
- -
RECQL4-related disorder Uncertain:1
The RECQL4 c.214-3C>A variant is predicted to interfere with splicing. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.082% of alleles in individuals of African descent in gnomAD. It is interpreted as uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/406957/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at